Sign in
av/in8bio-inc--big.svg

NASDAQ:INAB

IN8bio, Inc.

  • Stock

USD

Last Close

1.02

17/05 20:00

Market Cap

56.27M

Beta: -

Volume Today

37.48K

Avg: 3.83M

PE Ratio

−1.32

PFCF: −1.90

OverviewFinancialsFilingspeopleOwnershipAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Excel Tearsheet
Quarterly
Yearly
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
7.50K
-
average payables
489.50K
-
590K
20.53%
507.50K
13.98%
1.24M
144.93%
1.51M
21.28%
average receivables
15K
-
book value per share
0.75
-
-0.04
104.90%
0.94
2,656.81%
3.83
306.19%
1.08
71.69%
0.83
22.98%
capex per share
-0.12
-
-0.04
71.32%
-0.03
-
-0.18
470.11%
-0.01
92.33%
capex to depreciation
-7.89
-
-3.44
56.41%
-0.39
-
-3.36
756.60%
-0.22
93.42%
capex to operating cash flow
0.27
-
0.07
74.86%
0.02
-
0.15
571.52%
0.02
88.70%
capex to revenue
cash per share
0.81
-
0.07
91.96%
0.93
1,324.37%
3.71
300.98%
0.87
76.65%
0.71
17.82%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.01
-
0.06
585.92%
0.18
211.49%
0.15
18.36%
debt to equity
0.01
-
0.06
564.58%
0.26
309.40%
0.20
24.07%
dividend yield
earnings yield
-0.03
-
-0.05
62.31%
-0.04
19.52%
-0.33
660.23%
-0.57
69.08%
-0.73
28.62%
enterprise value
56.74M
-
93.21M
64.29%
176.49M
89.34%
9.16M
94.81%
36.13M
294.58%
24.82M
31.29%
enterprise value over ebitda
-28.79
-
-18.76
34.85%
-20.84
11.11%
-0.66
96.83%
-1.27
91.82%
-0.82
35.40%
ev to operating cash flow
-20.49
-
-19.42
5.24%
-24.74
27.44%
-0.68
97.26%
-1.50
120.98%
-1.06
28.99%
ev to sales
free cash flow per share
-0.57
-
-0.55
4.26%
-0.37
32.87%
-1.39
277.55%
-1.33
4.25%
-0.80
40.09%
free cash flow yield
-0.06
-
-0.05
4.26%
-0.04
32.87%
-0.32
760.03%
-0.57
81.96%
-0.58
0.29%
graham net net
0.61
-
-0.09
115.10%
0.79
958.95%
3.31
317.26%
0.38
88.65%
0.42
11.53%
graham number
2.39
-
0.67
71.80%
3.06
353.62%
11.25
268.19%
5.65
49.82%
4.34
23.07%
income quality
1.33
-
0.94
29.72%
0.83
10.86%
0.92
10.60%
0.85
8.27%
0.78
8.03%
intangibles to total assets
0
-
0
0
0
0.00
Infinity%
0
100%
interest coverage
-143.14
-
25.86
-
interest debt per share
0.00
-
0.01
-
0.24
2,599.42%
0.23
5.87%
0.16
28.00%
inventory turnover
invested capital
0.01
-
0.06
564.58%
0.26
309.40%
0.20
24.07%
market cap
61.73M
-
93.82M
52.00%
194.31M
107.10%
43.77M
77.48%
48.44M
10.67%
41.21M
14.91%
net current asset value
3.82M
-
-713K
118.65%
15.55M
2,281.63%
34.94M
124.62%
11.93M
65.86%
15.85M
32.92%
net debt to ebitda
2.53
-
0.12
95.15%
2.10
1,614.36%
2.50
18.64%
0.43
82.71%
0.54
25.19%
net income per share
-0.34
-
-0.55
62.31%
-0.44
19.52%
-1.47
233.74%
-1.31
11.03%
-1.00
23.16%
operating cash flow per share
-0.45
-
-0.51
14.07%
-0.37
28.26%
-1.36
269.11%
-1.15
15.10%
-0.78
32.06%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.35
-
-4.54
1,187.03%
-0.41
90.99%
-0.35
15.20%
-0.83
140.04%
-0.89
6.86%
revenue per share
roe
-0.45
-
14.84
3,413.45%
-0.47
103.15%
-0.38
17.84%
-1.21
214.30%
-1.20
0.23%
roic
-0.42
-
14.64
3,601.18%
-0.46
103.16%
-0.34
26.35%
-0.80
133.37%
0.08
110.37%
sales general and administrative to revenue
shareholders equity per share
0.75
-
-0.04
104.90%
0.94
2,656.81%
3.83
306.19%
1.08
71.69%
0.83
22.98%
stock based compensation to revenue
tangible asset value
4.65M
-
-346K
107.45%
18.32M
5,395.09%
38.18M
108.41%
22.61M
40.80%
24.94M
10.31%
tangible book value per share
0.75
-
-0.04
104.90%
0.94
2,656.81%
3.83
306.19%
1.08
71.85%
0.83
22.55%
working capital
4.65M
-
116K
97.51%
15.57M
13,324.14%
36.72M
135.83%
16.41M
55.31%
19.23M
17.18%

All numbers in USD (except ratios and percentages)